We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

EU GDPR Sample Clauses

EU GDPRIn relation to Personal Data that is protected by the EU GDPR, the EU SCCs are incorporated and will apply completed as follows: Module 2 of the EU SCCs applies between Customer as "data exporter" and ClickDimensions as "data importer" on the following basis: (i) in Clause 7, the optional docking clause will apply, (ii) in Clause 9, Option 2 will apply, and the time period for prior notice of Sub-Processor changes shall be as set out in Section 11(c) of this Addendum, (iii) in Clause 11, the optional language shall not apply, (iv) in Clause 17, Option 1 will apply, and the EU SCCs will be governed by , (v) in Clause 18(b), disputes shall be resolved before the courts of , (vi) Annex 1 to the EU SCCs will be deemed to incorporate Schedule 1 to this Addendum and (vii) Annex 2 to the EU SCCs will be deemed to incorporate Schedule 2 of this Addendum.
EU GDPR. Supplier agrees to comply with the provisions of the GDPR at the University’s request, if practicable, including but not limited: collecting the minimum amount of information necessary to perform its duties, limiting retention of personal data as specified therein, deleting information specific to individuals upon request – except as necessary to perform its job function, and responding to requests from the instructor for the status of individuals’ data. Supplier shall assume responsibility for interacting with any and all individual inquiries to Supplier constituting a request under the GDPR.
EU GDPR. Totaljobs shall inform the customer without undue delay if a data subject contacts Totaljobs directly for the purpose of providing access, rectification, erasure or restricting the processing of their personal data. Totaljobs shall support the customer in carrying out data protection impact assessments pursuant to Art. 35 EU GDPR and the resulting consultation of the supervisory authority pursuant to Art. 36 EU GDPR to the necessary extent. Totaljobs shall support the customer with regard to compliance with reporting and notification obligations in the event of data protection breaches within the meaning of Artt. 33 and 34 EU GDPR.
EU GDPR. You have the right to demand from the person responsible the limitation of the processing of your personal data.
EU GDPR. You have the right to object at any time to the processing of your relevant data. • Article 7 EU-GDPR, you have the right to withdraw consent to the processing of your personal data at any time. When you withdraw your consent, the personal data used between your acquiescence to consent and your withdrawal of consent is lawfully used data. Herewith I agree to the processing of my personal data in the above scope and for the purposes stated therein, by the responsible persons. I have received the information required under the EU General Data Protection Regulations (EU-GDPR). I am content with the conditions as well as the rights granted to me under this agreement. Date Signature of Research Participant Date Signature of Researcher Attachment 5: Researcher Commitment Form Promoting Research on Digitalisation in Emerging Powers and Europe Towards Sustainable Development How to interpret this form: This form is to be read and signed by the Researcher. This form is the Researcher's commitment to ethical research practices. Please make yourself knowledgeable of the PRODIGEES Data Protection Policy, as well as the European Union General Data Protection Regulations (EU-GDPR). Please return this signed commitment to the PRODIGEES project manager and your host supervisor.
EU GDPR. You have the right to information and may request a copy of your data processed by us. • Article 16 EU-GDPR: You have the right to make corrections and make sure that your data is complete.
AutoNDA by SimpleDocs
EU GDPR. If Company creates, accesses, transmits or stores Villanova Data that is subject to the European Union’s Regulation (EU) 2016/679 (“Regulation on the protection of natural persons with regard to the processing of personal data and on the free movement of such data,” or the “EU GDPR”), Villanova and Company agree as follows: 1. For purposes of this Section, the terms Process/Processor/Processing, Personal Data, Third Country, International Organization, Member State, and Data Subject shall be defined and construed as set forth in the EU GDPR. 2. Company agrees to implement appropriate technical and organizational measures in compliance with the requirements of the EU GDPR. 3. Company shall not engage another Processor without prior specific or general written authorization of Villanova. If a general written authorization is provided, Company shall inform Xxxxxxxxx of any intended changes concerning the addition or replacement of other Processors and provide Villanova the opportunity to object to such changes. If any other Processor is engaged, Company shall ensure that the Processor shall comply with all data protection obligations as set forth herein and otherwise required by the EU GDPR. Company shall remain fully liable to Villanova for the performance of any other Processor’s obligations. 4. Company shall only engage in Processing (including with respect to subject matter, duration, nature and purpose of the Processing) as necessary to carry out its obligations under the Agreement and as set forth in greater detail therein. Company shall reasonably assist Villanova in carrying out any and all of its obligations under the EU GDPR, as applicable and within the scope of the Agreement. Company shall Process Personal Data only on documented instructions from Villanova, including with regard to transfers of Personal Data to a Third Country of International Organization, unless required to do so by European Union or Member State law to which Company is subject; in such a case, Company shall inform Villanova of that legal requirement before Processing, unless that law prohibits such information on important grounds of public interest. Company shall immediately inform Villanova if, in its opinion, an instruction infringes the EU GDPR or other European Union or Member State data protection provisions. 5. Company shall ensure that all personal authorized to Process the Personal Data have committed themselves to confidentiality or are under an appropriate statutory...
EU GDPR. The customer names a legitimate point of contact who is entitled to give instructions according to this DPA and informs about any changes in a known way.

Related to EU GDPR

  • GDPR SAP and Customer agree that it is each party’s responsibility to review and adopt requirements imposed on Controllers and Processors by the General Data Protection Regulation 2016/679 (“GDPR”), in particular with regards to Articles 28 and 32 to 36 of the GDPR, if and to the extent applicable to Personal Data of Customer/Controllers that is processed under the DPA. For illustration purposes, Appendix 3 lists the relevant GDPR requirements and the corresponding sections in this DPA.

  • DPR A DPR is 1/365th of an APR, rounded to one tenthousandth of a percentage point. Your DPRs are shown in How Rates and Fees Work on page 2 of Part 1.

  • Technology Research Analyst Job# 1810 General Characteristics

  • Marketing Plan The MCOP shall submit an annual marketing plan to ODM including all planned activities for promoting membership in or increasing awareness of the MCOP. The marketing plan submission shall include an attestation by the MCOP that the plan is accurate and is not intended to mislead, confuse, or defraud the eligible individuals or ODM.

  • TECHNICAL EVALUATION (a) Detailed technical evaluation shall be carried out by Purchase Committee pursuant to conditions in the tender document to determine the substantial responsiveness of each tender. For this clause, the substantially responsive bid is one that conforms to all the eligibility and terms and condition of the tender without any material deviation. The Institute’s determination of bid’s responsiveness is to be based on the contents of the bid itself without recourse to extrinsic evidence. The Institute shall evaluate the technical bids also to determine whether they are complete, whether required sureties have been furnished, whether the documents have been properly signed and whether the bids are in order. (b) The technical evaluation committee may call the responsive bidders for discussion or presentation to facilitate and assess their understanding of the scope of work and its execution. However, the committee shall have sole discretion to call for discussion / presentation. (c) Financial bids of only those bidders who qualify the technical criteria will be opened provided all other requirements are fulfilled. (d) AIIMS Jodhpur shall have right to accept or reject any or all tenders without assigning any reasons thereof.

  • Tests and Preclinical and Clinical Trials The studies, tests and preclinical and clinical trials conducted by or, to the Company’s knowledge, on behalf of the Company were and, if still ongoing, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional scientific standards and all Authorizations and Applicable Laws, including, without limitation, the Federal Food, Drug and Cosmetic Act and the rules and regulations promulgated thereunder (collectively, “FFDCA”); the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the General Disclosure Package and the Prospectus are, to the Company’s knowledge, accurate in all material respects and fairly present the data derived from such studies, tests and trials; except to the extent disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, the Company is not aware of any studies, tests or trials, the results of which the Company believes reasonably call into question the study, test, or trial results described or referred to in the Registration Statement, the General Disclosure Package and the Prospectus when viewed in the context in which such results are described and the clinical state of development; and, except to the extent disclosed in the Registration Statement, the General Disclosure Package or the Prospectus, neither the Company nor any Subsidiary has received any notices or correspondence from the FDA or any Governmental Entity requiring the termination or suspension of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials, copies of which communications have been made available to you.

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Commercialization Plan At such times as the JGC will deem appropriate, the JGC will direct the Parties to mutually prepare a Worldwide Commercialization Plan, and the JGC will review and approve such initial Worldwide Commercialization Plan. Thereafter, the JGC will have one or the other Party (or both) update the Worldwide Commercialization Plan each calendar year, and the JGC will review and approve any such update or any other amendment to the Worldwide Commercialization Plan. Notwithstanding anything in this CCPS Agreement to the contrary, the Parties acknowledge and agree that (i) Bluebird may decline to perform any Commercialization activity proposed to be conducted by Bluebird in the Worldwide Commercialization Plan (other than Manufacturing of Vectors and associated Payloads), and (ii) the Worldwide Commercialization Plan will not include, and Bluebird will have no obligation to perform, any such Commercialization activity that Bluebird has declined to perform, provided that once Bluebird has agreed to perform a Commercialization activity, it will be obligated to perform, and cannot decline to perform, such activity. In addition, either Party may request at any time that the JGC consider and approve other updates to the Worldwide Commercialization Plan. Further: (a) The JGC will set the required form and contents of the Worldwide Commercialization Plan. The Worldwide Commercialization Plan will reflect a singular marketing and sales approach worldwide, and will specify, among other things, the number of sales reps in the U.S. for each Party, allocation of regions in the U.S. for each Parties’ sales force, creation of marketing materials, planning for conferences, and other marketing activities. CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. (b) Neither Party (itself or by or through any others, including any Affiliates or Sublicensees) will take any material action regarding the Commercialization of Licensed Product unless described in the Worldwide Commercialization Plan or approved by the JGC. (c) All Commercialization of Licensed Product for U.S. Administration will be conducted under the supervision of the JGC and as part of the U.S. Development & Commercialization Program. (d) Celgene will have final decision making authority for all Commercialization activities worldwide, including timing of launch and pricing and the Worldwide Development Plan.

  • MINISTRY/SCHOOL BOARD INITIATIVES ETFO will be an active participant in the consultation process to develop a Ministry of Education PPM regarding Ministry/School Board Initiatives.

  • Procurement of Goods and Services (a) If the HSP is subject to the procurement provisions of the BPSAA, the HSP will abide by all directives and guidelines issued by the Management Board of Cabinet that are applicable to the HSP pursuant to the BPSAA. (b) If the HSP is not subject to the procurement provisions of the BPSAA, the HSP will have a procurement policy in place that requires the acquisition of supplies, equipment or services valued at over $25,000 through a competitive process that ensures the best value for funds expended. If the HSP acquires supplies, equipment or services with the Funding it will do so through a process that is consistent with this policy.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!